EGFR stage IV population in FJD
Published: 6 December 2024| Version 1 | DOI: 10.17632/kxwjck3826.1
Contributors:
Jaime Rubio, , , , , , Description
Patients diagnosed with metastatic EGFR-mutated NSCLC who were treated in four hospitals in Madrid, Spain. The characteristics of these patients were analyzed. We selected those diagnosed between March 2021 and February 2023, coinciding with the implementation of next-generation sequencing (NGS) as part of routine clinical practice for lung cancer patients in our centers.
Files
Steps to reproduce
We performed a manual data extraction from medical records and analyzed PFS and OS. All statistical analyses were carried out using the software tool SPSS v20 for Windows (SPSS Inc., Chicago, IL, USA).
Institutions
Instituto de Investigacion Sanitaria de la Fundacion Jimenez Diaz
Categories
Database